Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
YARDLEY, Pa., Feb. 17, 2020 (GLOBE NEWSWIRE) -- On February 7, 2020, Jubilant DraxImage Inc., and certain of its affiliates (“Jubilant”) were informed by the U.S. Patent Office that it agreed with...
-
新澤西州普林斯頓市, Nov. 01, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, 一家私人控股的研發，生產，和銷售製劑產品的製藥公司,今天宣布其已獲得美國食品與藥物管理局（FDA）的第八個ANDA文號批准。 第八個ANDA的產品名為利多卡因軟膏 5% (Lidocaine Ointment USP 5%), 每管規格為1.5盎司（35.44克）...
-
新泽西州普林斯顿市, Nov. 01, 2019 (GLOBE NEWSWIRE) -- 2019 年 10 月 31 日: SunGen Pharma, 一家私人控股的研发，生产，和销售制剂产品的制药公司,今天宣布其已获得美国食品与药物管理局（FDA）的第八个 ANDA文号批准。 第八个ANDA的产品名为利多卡因软膏 5% (Lidocaine Ointment USP 5%),...
-
PRINCETON, N.J., Oct. 31, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products,...
-
NORTHVALE, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...
-
PRINCETON, N.J., Dec. 11, 2018 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products,...
-
PRINCETON, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products,...
-
NORTHVALE, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...
-
SAINT LAURENT, Quebec, Nov. 08, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) today reported financial results for the third quarter...
-
NORTHVALE, N.J., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and...